Multiepitope-based peptide vaccines carrying conserved CD4+, CD8+ T-cell, and B-cell epitopes among HFMD-associated enteroviruses may induce a broad spectrum of protective immune responses. Here, CD4 is linked to hand, foot and mouth disease.